Koers Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Aandelen
6990
CNE1000062J1
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
168,3 HKD | +0,24% | +20,65% | +63,56% |
Omzet 2024 * | 1,16 mld. 160 mln. 1,25 mld. 150 mln. | Omzet 2025 * | 1,49 mld. 205 mln. 1,61 mld. 192 mln. | Marktkapitalisatie | 34,14 mld. 4,72 mld. 36,89 mld. 4,42 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -625 mln. -86,33 mln. -675 mln. -80,82 mln. | Nettowinst (verlies) 2025 * | -684 mln. -94,48 mln. -739 mln. -88,45 mln. | EV/omzet 2024 * | 29,1 x |
Nettoliquiditeiten 2024 * | 464 mln. 64,12 mln. 502 mln. 60,03 mln. | Nettoliquiditeiten 2025 * | 639 mln. 88,28 mln. 691 mln. 82,65 mln. | EV/omzet 2025 * | 22,5 x |
K/w-verhouding 2024 * |
-52,5
x | K/w-verhouding 2025 * |
-48,3
x | Werknemers | 1.446 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 55,25% |
1 dag | +0,24% | ||
1 week | +20,65% | ||
Lopende maand | +8,58% | ||
1 maand | +8,58% | ||
3 maanden | +94,45% | ||
6 maanden | +118,71% | ||
Lopend jaar | +63,56% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Jun You Ge
CEO | Chief Executive Officer | 51 | 08-02-21 |
Ze Jian Zhou
DFI | Director of Finance/CFO | 41 | 25-02-22 |
Xiang Yang Tan
CTO | Chief Tech/Sci/R&D Officer | 61 | 05-07-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Ge Xin Liu
FOU | Founder | 73 | 22-11-16 |
Si Chuan Liu
BRD | Director/Board Member | 40 | 22-11-16 |
Hao Feng
BRD | Director/Board Member | 44 | 12-02-21 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
30-04-24 | 168,3 | +0,24% | 233 800 |
29-04-24 | 167,9 | -0,06% | 278 600 |
26-04-24 | 168 | +9,16% | 484 184 |
25-04-24 | 153,9 | -0,06% | 318 406 |
24-04-24 | 154 | +4,19% | 441 724 |
uitgestelde koers Hong Kong S.E., 30 april 2024 om 10:08 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+63,56% | 4,7 mld. | |
-3,05% | 102 mld. | |
+1,42% | 96,29 mld. | |
+2,13% | 22,18 mld. | |
-15,61% | 21,2 mld. | |
-9,21% | 18,31 mld. | |
-39,98% | 17,38 mld. | |
-14,34% | 16,36 mld. | |
+4,50% | 13,97 mld. | |
+32,39% | 12,17 mld. |